The results of a study published in the Journal of Clinical Gastroenterology show that patients who suffer from inflammatory bowel disease (IBD) have reported experiencing fewer symptoms and making fewer trips to the hospital after using cannabis-based products.
IBD refers to two conditions, Crohn’s disease and ulcerative colitis (UC), which are long-term medical issues that cause chronic inflammation of the gastrointestinal tract. Symptoms of IBD such as pain, cramps or swelling in the stomach, weight loss, and extreme tiredness. There is not currently a cure for either Crohn’s or UC.
The average frequency of cannabis use in IBD patients was once a week, according to researchers at the Albert Einstein College of Medicine in New York City who surveyed 236 IBD patients accessing medical cannabis from dispensaries in Minnesota and New York. The most common form of consumption found amongst survey respondents was high-THC vape pens.
The study found that after using medical cannabis, respondents reported fewer emergency room visits and a decreased impact of symptoms on their daily lives. Furthermore, researchers noted that those with IBD who used medical cannabis perceived symptom benefits without any serious adverse effects.
Previous studies conducted have illustrated similar, promising outcomes for patients with IBD. In a study observing 21 patients with Crohn’s disease, it was found that 45% of those who partook in smoking cannabis achieved clinical remission after 8 weeks, compared to the 10% placebo group. Out of the three participants who also reported dependency on steroids, they noted that cannabis reduced their dependency.
A study earlier in 2022 showed that nearly 1/2 a million people suffer from IBD in the UK, almost double what was estimated before. Research commissioned by Crohn’s & Colitis UK suggests that 1 in 123 people struggle with this disease. Even though patients are unlikely to be able to get medical cannabis prescribed by NHS, it is possible via a private clinic.
Cannabis is an effective treatment for other chronic inflammatory conditions such as arthritis, lupus, and multiple sclerosis. The anti-inflammatory and immunomodulatory effects of cannabis make it a promising option for treating IBD.
While more research is needed to determine the long-term efficacy of cannabis in treating IBD, the current evidence suggests that it can help reduce symptoms and improve the quality of life for patients with this condition. However, it is important to talk to your doctor before starting any new treatment, especially if you are taking other medications.
